William Doyle
Chairman of the Board of DirectorsatNovoCure· In proxies 2023–2025
William Doyle sits on 5 public boards.
Boards1
- NovoCureChair · 21 yr on the boardNot independent—Paid as an executive
Board seats come from each company's latest proxy statement.
Experience
- NovoCurePublic company · 2 yr
- Chairman of the Board of Directors2024 – Present · 2 yrStock in role +5%
- Elanco Animal HealthPublic company · 3 yr
- Director2023 – Present · 3 yrNo stock prices for these years
- Director of ProKidney Corp. since 2022. Formerly a director of Elanco Animal Health, Inc. from 2020 to 2025, Minerva Neurosciences, Inc. from 2017 to 2023, OptiNose, Inc. from 2004 to 2020 and Zoetis, Inc. from 2015 to 2016Public company
- Director? – PresentNo stock prices for these years
- Cordis CorporationPublic company
- Director? – PresentNo stock prices for these years
- Johnson & Johnson Development CorporationPublic company
- Director? – PresentNo stock prices for these years
Roles come from the proxy statements of each company.
Activity
No new filings about this person in the feed.
Two people shown as one, or a wrong number?